CopyMark Law Group
4.9/5
Drawing for PURAPHARM

USPTO serial 97642580

PURAPHARM

Reviewed by CopyMark Law Group

Reg. 7182789Status 700Registered
Filing date
Status date
Registration date
Oct 3, 2023
Examiner
GERMICK JR., EDWARD JOSEPH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PURAPHARM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Haverly MacArthur

Haverly MacArthur ADAMS AND REESE LLP1600 WEST END AVENUESUITE 1400NASHVILLE, TN 37203

Goods and services

ClassDescriptionStatusFirst use
005health food supplements; herbal extracts for medical purposes in the form of capsules, tablets, powder, and granules; vitamins, vitamin preparations, mineral preparations, and enzymes for medical and veterinary purposes; enzyme preparations for medical purposes and veterinary purposes; dietary and nutritional supplements; powdered nutritional supplement drink mix; pharmaceutical and medicinal preparations and substances for strengthening the immune system and restoring normal bodily functions, the treatment, mitigation and prevention of diseases and disorders, namely, digestive diseases and disorders, obesity, central nervous system diseases and disorders, namely, brain diseases, cognitive disorders, movement disorders, ocular motility, respiratory diseases and disorders, excretory diseases and disorders, cardiovascular diseases and disorders, reproductive diseases and disorders, endocrinal diseases and disorders, immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndrome, hepatitis, dermatological diseases and disorders, skeletal diseases and disorders, namely, bone diseases, back pain, muscular diseases and disorders, namely, muscular dystrophy, inflammatory muscle diseases, sensory diseases and disorders, namely, blindness; chemical preparations for medical and pharmaceutical purposes, namely, for strengthening the immune system and restoring normal bodily functions, the treatment, mitigation and prevention of diseases and disorders, namely, digestive diseases and disorders, obesity, central nervous system diseases and disorders, namely, brain diseases, cognitive disorders, movement disorders, ocular motility, respiratory diseases and disorders, excretory diseases and disorders, cardiovascular diseases and disorders, reproductive diseases and disorders, endocrinal diseases and disorders, immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndrome, hepatitis, dermatological diseases and disorders, skeletal diseases and disorders, namely, bone diseases, back pain, muscular diseases and disorders, namely, muscular dystrophy, inflammatory muscle diseases, sensory diseases and disorders, namely, blindness; dietetic food preparations and dietetic beverages adapted for medical purposes; dietetic substances, namely, dietetic sugar for medical use, and dietetic foods adapted for medical use; dietetic preparations adapted for medical purposes; digestives for pharmaceutical purposes; medicinal drinks; appetite suppressants; medical preparations and medicines for appetite control and weight management; balms for medical purposes; medicated lotions for skin, hair, sunburn, face, and body; analgesics; sedatives; tranquilizers; sunburn ointments; sunburn preparations for pharmaceutical purposes; pharmaceutical preparations for skin care; medicinal mud, namely, herbal mud packs for therapeutic purposes; mouth washes for medical purposes; medicines for dental purposes; sanitary preparations for medical purposes and for personal hygiene, other than toiletries; air, toilet, and room deodorants; veterinary nutritional supplements; medicated grooming preparations for cats, dogs, and pets, namely, shampoos, ear wash, ear drops, soap bars for animalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 3, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 3, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 18, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 18, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 28, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 14, 2023FIXDELECTRONIC RECORD REVIEW COMPLETE—
Jun 9, 2023ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Jun 2, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 2, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Jun 2, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 2, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 2, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
May 3, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 27, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 27, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 2, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 2, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 2, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 28, 2022DOCKASSIGNED TO EXAMINER—
Nov 6, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 25, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance